Abbott has received Conformite Europeene (CE) marking for the Architect Galectin-3 assay, a blood test to aid doctors in assessing the prognosis of patients diagnosed with chronic heart failure.

The Obama administration has released the long-anticipated budget proposal for fiscal 2014. Although the document did not include specific reductions in reimbursement for advanced diagnostic imaging services, the fiscal 2014 budget would largely exclude certain imaging services from the in-office ancillary services exception (IOASE) to the Stark self-referral law and calls for prior authorization for advanced imaging services.

Multi-detector computed tomography (MDCT) is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography according to a new study.

Accumetrics Inc. announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to assess whether a patient may be at greater risk for both bleeding or ischemic events, as an aid to manage therapeutic treatment decisions and accurately assess the antiplatelet effect from P2Y12 inhibitors (such as clopidogrel, prasugrel and ticagrelor).